Jubilant Life Sciences has issued Commercial Papers (CPs) of Rs 50 crore. The tenure of the instrument is 70 days and allotted on January 11, 2017. The coupon/interest will be paid upfront at the rate of 6.68% per annum on maturity i.e. March 22, 2017. With this issue, the aggregate amount of commercial papers outstanding as on date is Rs 150 crore.
Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.
